FGF 23 was confirmed to be a major contributor to left ventricular hypertrophy through a klotho-independent pathway [6], but its relation to atherosclerosis, endothelial dysfunction, and vascular calcifications is questionable, especially at the early stages of CKD. This evidence concerns the gene KL and left ventricular hypertrophy.